These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave. Cheron G; Piette T; Thiriaux A; Jacquy J; Godaux E Electroencephalogr Clin Neurophysiol; 1994 Nov; 92(6):491-501. PubMed ID: 7527767 [TBL] [Abstract][Full Text] [Related]
6. [Maps of somatosensory evoked potentials from the arm in patients with neoplasms and post-traumatic brain lesions]. Paradiso C; Caruso V; Rossi S; Cioni R; Passero S; Giannini F; Ravenni R; Battistini N Riv Neurol; 1991; 61(6):228-32. PubMed ID: 1813975 [TBL] [Abstract][Full Text] [Related]
7. Time course of frontal somatosensory evoked potentials. Relation to L-dopa plasma levels and motor performance in PD. Ulivelli M; Rossi S; Pasqualetti P; Rossini PM; Ghiglieri O; Passero S; Battistini N Neurology; 1999 Oct; 53(7):1451-7. PubMed ID: 10534250 [TBL] [Abstract][Full Text] [Related]
8. Changes in the amplitude of the N30 frontal component of SEPs during apomorphine test in parkinsonian patients. de Mari M; Margari L; Lamberti P; Iliceto G; Ferrari E J Neural Transm Suppl; 1995; 45():171-6. PubMed ID: 8748623 [TBL] [Abstract][Full Text] [Related]
9. Statistical analysis of topographic maps of short-latency somatosensory evoked potentials in normal and parkinsonian subjects. Babiloni F; Babiloni C; Cecchi L; Onorati P; Salinari S; Urbano A IEEE Trans Biomed Eng; 1994 Jul; 41(7):617-24. PubMed ID: 7927382 [TBL] [Abstract][Full Text] [Related]
10. N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study. Traversa R; Pierantozzi M; Semprini R; Loberti M; Cicardi MC; Bassi A; Stanzione P J Neural Transm Suppl; 1995; 45():177-85. PubMed ID: 8748624 [TBL] [Abstract][Full Text] [Related]
11. Abnormalities of somatosensory evoked potentials in spasmodic torticollis. Mazzini L; Zaccala M; Balzarini C Mov Disord; 1994 Jul; 9(4):426-30. PubMed ID: 7969209 [TBL] [Abstract][Full Text] [Related]
12. Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease. Mauguière F; Broussolle E; Isnard J Electroencephalogr Clin Neurophysiol; 1993; 88(4):243-54. PubMed ID: 7688279 [TBL] [Abstract][Full Text] [Related]
13. The N30 component of somatosensory evoked potentials in patients with dystonia. Reilly JA; Hallett M; Cohen LG; Tarkka IM; Dang N Electroencephalogr Clin Neurophysiol; 1992; 84(3):243-7. PubMed ID: 1375883 [TBL] [Abstract][Full Text] [Related]
14. The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease. Garcia PA; Aminoff MJ; Goodin DS Neurology; 1995 May; 45(5):989-92. PubMed ID: 7746421 [TBL] [Abstract][Full Text] [Related]
15. Scalp-recorded short and middle latency peroneal somatosensory evoked potentials in normals: comparison with peroneal and median nerve SEPs in patients with unilateral hemispheric lesions. Molaie M Electroencephalogr Clin Neurophysiol; 1987 Mar; 68(2):107-18. PubMed ID: 2435527 [TBL] [Abstract][Full Text] [Related]
16. Potentials evoked in human and monkey cerebral cortex by stimulation of the median nerve. A review of scalp and intracranial recordings. Allison T; McCarthy G; Wood CC; Jones SJ Brain; 1991 Dec; 114 ( Pt 6)():2465-503. PubMed ID: 1782527 [TBL] [Abstract][Full Text] [Related]
17. Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes. Pierantozzi M; Sabato AF; Leonardis F; Marciani MG; Cicardi C; Giacomini P; Bernardi G; Stanzione P Exp Brain Res; 2000 Aug; 133(3):368-76. PubMed ID: 10958527 [TBL] [Abstract][Full Text] [Related]
20. Short-latency median nerve somatosensory evoked potentials in three cases of parkinsonism and dopa responsive dystonia. Margari L; de Mari M; Lamberti P; Iliceto G; Serlenga L; Perniola T; Rossini PM; Ferrari E Funct Neurol; 1995; 10(2):99-105. PubMed ID: 7557558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]